Marie Lachâtre

Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia

Olivier Hermine, Xavier Mariette, Pierre‐Louis Tharaux et al. · JAMA Internal Medicine · 2020 · 777 citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +14

Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial

Pierre‐Louis Tharaux, Gilles Pialoux, Arthur Pavot et al. · The Lancet Respiratory Medicine · 2021 · 296 citations · Full text

Veterinary Medicine, Immunology, Pharmacotherapy +14

Discontinuing β-lactam treatment after 3 days for patients with community-acquired pneumonia in non-critical care wards (PTC): a double-blind, randomised, placebo-controlled, non-inferiority trial

Aurélien Dinh, Jacques Ropers, Clara Duran et al. · The Lancet · 2021 · 162 citations

Pharmacy, Pharmacotherapy, Antimicrobial Pharmacotherapy +13

Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis

Lorenzo Guglielmetti, Marie Jaspard, Damien Le Dû et al. · European Respiratory Journal · 2016 · 155 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France

Paul Loubet, N. Lenzi, Martine Valette et al. · Clinical Microbiology and Infection · 2016 · 109 citations · Full text

Veterinary Medicine, Infectious Diseases, Infectious Disease Epidemiology +12